Savient Pharmaceuticals, Inc. to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that Christopher G. Clement, President and Chief Executive Officer, and Zeb Horowitz M.D., Chief Medical Officer of Savient Pharmaceuticals, will present a corporate update at the upcoming 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference that will be held at the Grand Hyatt Hotel in New York.
MORE ON THIS TOPIC